Tokyo

London

New York

Register

Sign In

EUR/USD

1.1193

0.0043

0.39%

GBP/USD

1.2720

0.0040

0.32%

USD/JPY

111.30

0.0070

0.01%

USD/CHF

0.9694

-0.0026

-0.26%

EUR/GBP

0.8800

0.0006

0.07%

USD/CAD

1.3269

0.0034

0.26%

NZD/USD

0.7281

0.0015

0.20%

EUR/JPY

124.58

0.4895

0.39%

EUR/CHF

1.0850

0.0014

0.13%

Esperion Therapeutics Inc.

NASDAQ: ESPRHealthcare / Biotechnology / USA
44.34+2.03+4.80%Vol 764 4541Y Perf 162.37%
Jun 23rd, 2017 16:00
BID43.02 ASK44.87
Open43.17 Previous Close42.31
Pre-Market- After-Trading44.87
 - -%  0.53 1.20%
Target Price
36.25 
Analyst Rating
Hold 2.56
Potencial %
-18.25 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-75/-27 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-100/-99 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-98 
Income Ranking
—    -
Market Cap (mil)956 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
90.03 
Earnings Date
3rd Aug 2017

Today's Price Range

41.4244.54

 

52wk Range

9.4048.21

Summary:

Strong Buy

Technical Indicators: Strong Buy
Moving Averages: Strong Buy
Performance
1 Month
25.33%
3 Months
8.46%
6 Months
234.20%
1 Year
162.37%
3 Years
175.99%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ESPR44.342.03004.80
AAPL146.350.72000.49
GOOG965.598.50000.89
MSFT71.210.95001.35
XOM81.610.53000.65
WFC52.45-0.0400-0.08
JNJ136.430.38000.28
FB155.071.67001.09
GE27.570.02000.07
JPM86.86-0.1600-0.18
...

TickerPriceChg.%52 Week High
EQT56.198.0080.61
AA31.094.3339.78
SWN5.794.3215.59
RRC22.263.8745.76
COG23.743.8526.74
WDC93.343.4295.00
TRIP36.963.4171.69
OKE49.192.9359.47
MOS22.972.9134.36
RIG8.092.8016.66
FCX11.762.7117.06
AKAM51.302.5671.64
ALGN153.502.55154.85
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 8.40
Current Ratio 8.70
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.01
Interest Coverage -302.10
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.92
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -10.40
Cash Flow Per Share -3.20
Price to Tangible Book3.92
Book Value per Share8.52
Enterprise Value (in ths.)574 719
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-35.99
ROE last 12 Months -42.93
Return on Assets (5Y Avg) -15.90
ROA last 12 Months -40.32
Return on Capital (5Y Avg) -
ROC last 12 Months -42.23
Return on invested Capital Q -19.00
Return on invested Capital Y-28.53
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-1.48-1.80-21.62
Q04 2016-1.15-1.29-12.17
Q03 2016-0.88-0.7712.50
Q02 2016-0.79-0.6221.52
Q01 2016-0.74-0.6512.16
Q04 2015-0.61-0.584.92
Q03 2015-0.60-0.575.00
Q02 2015-0.65-0.5515.38
Earnings Per EndEstimateRevision %Trend
6/2017 QR-1.73-13.82Negative
9/2017 QR-1.74-12.26Negative
12/2017 FY-6.86-11.91Negative
12/2018 FY-4.964.62Positive
Next Report Date3rd Aug 2017
Estimated EPS Next Report-1.73
Estimates Count2
EPS Growth Next 5 Years %0.00
Volume Overview
Volume764 454
Shares Outstanding (in ths.)22 590
Trades Count3 175
Dollar Volume23 275 723
Avg. Volume1 405 239
Avg. Weekly Volume879 479
Avg. Monthly Volume717 055
Avg. Quarterly Volume820 772

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (22.22 %)
2 (22.22 %)
1 (11.11 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (11.11 %)
Hold
7 (77.78 %)
7 (77.78 %)
7 (77.78 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
2.56
Hold
2.56
Hold
2.67

There are no comments yet.

News

Plus500
x